Literature DB >> 3853984

Comparison of fosfomycin and vancomycin therapy for experimental endocarditis due to methicillin-resistant Staphylococcus epidermidis.

A Rodríguez, M V Vicente, T Olay.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3853984     DOI: 10.1007/bf02013412

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN: 0722-2211            Impact factor:   3.267


× No keyword cloud information.
  5 in total

1.  International collaborative study on standardization of bacterial sensitivity to fosfomycin.

Authors:  J M Andrews; F Baquero; J M Beltran; E Canton; F Crokaert; M Gobernado; R Gomez-Ius; E Loza; M Navarro; T Olay
Journal:  J Antimicrob Chemother       Date:  1983-10       Impact factor: 5.790

2.  Pharmacokinetics of fosfomycin.

Authors:  W M Kirby
Journal:  Chemotherapy       Date:  1977       Impact factor: 2.544

3.  Therapy of methicillin-resistant Staphylococcus epidermidis experimental endocarditis.

Authors:  F D Lowy; M A Wexler; N H Steigbigel
Journal:  J Lab Clin Med       Date:  1982-07

4.  Fosfomycin: Laboratory studies.

Authors:  H B Woodruff; J M Mata; S Hernández; S Mochales; A Rodríguez; E O Stapley; H Wallick; A K Miller; D Hendlin
Journal:  Chemotherapy       Date:  1977       Impact factor: 2.544

5.  Antibiotic therapy of experimental Staphylococcus epidermidis endocarditis.

Authors:  G J Vazquez; G L Archer
Journal:  Antimicrob Agents Chemother       Date:  1980-02       Impact factor: 5.191

  5 in total
  2 in total

1.  Single- and combination-antibiotic therapy for experimental endocarditis caused by methicillin-resistant Staphylococcus aureus.

Authors:  A Rodríguez; M V Vicente; T Olay
Journal:  Antimicrob Agents Chemother       Date:  1987-09       Impact factor: 5.191

2.  The microbiological efficacy of the combination of fosfomycin and vancomycin against clinically relevant staphylococci.

Authors:  S Gatermann; E Schulz; R Marre
Journal:  Infection       Date:  1989 Jan-Feb       Impact factor: 3.553

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.